The technology is expected to be developed into a hand-held device for use in the critical ‘golden hour’ after traumatic brain injury
Unit 9 launched in 2022 to provide much-needed space for Birmingham’s biomedical innovators.
EvoPhase will use an AI-led ‘evolutionary design’ approach that is applicable to a diverse range of equipment, across many industries.
The assistive AI platform has been tested independently by Oxbridge, who ran their English marking through the platform with remarkable results.
One of only 17 projects selected by the MSP, which aims to build secure, responsible mineral supply chains to meet net zero-carbon goals.
The project involving will see university researchers work with Cooksongold Additive Manufacturing to develop precious metal alloys for 3D printing
The new method can simplify battery recycling, which currently concentrates on recycling elements by dissolving battery cathodes using strong acids
The URC is collaborating with Marker Diagnostics, which was founded in 2016 following pioneering concussion research at the University of Birmingham.
Multiple organisations from across the region are joining the University of Birmingham to drive new healthcare technologies towards commercialisation.
Birmingham researchers created antibody fragments called nanobodies to help scientists understand more about platelet disorders such as bleeding or thrombosis
Dr Yi Wang was shortlisted for a new ‘phase shifter’ technology that will reduce signal loss in antenna systems
BiMaTs will offer a range of services including developing protocols that are specific to the needs of individual clients
The "Re-RE Wind" partnership seeks to play a pivotal role in securing the future of sustainable wind energy.
A new partnership agreement will bring the University of Birmingham’s mineral extraction expertise to new markets.
The antibody targets a section of signalling proteins that play a central role in sustaining inflammation during onset and progression of autoimmune diseases
The study aims to identify biomarkers in blood, urine, or saliva, for rapid diagnosis so patients are routed directly to the most appropriate treatment centre.
Leading venture capital companies have invested in Delta g to enable their vision of creating the ‘Google Maps for the underground space’
The founders met as graduate researchers at the University. Their company is offering solutions to the global water scarcity crisis.
Co-founded by eight Midlands universities, Midlands Mindforge will support the creation and growth of university spinouts and IP rich companies in the region
Birmingham research underpins the concussion test which was used throughout the collaboration
The study shows how silver impregnated into ‘bioactive glass’ delivers more long-lasting antimicrobial wound protection than conventional alternatives
The seed round had participation from HighSage Ventures, Vireo Ventures, Rishi Khosla, Plug & Play Ventures, and Electric Revolution Ventures.
Funds awarded to Linear Diagnostics for rapid point-of-care test for gonorrhoea and Chlamydia in men who have sex with men, and women who have sex with women.
Marker Diagnostics, which developed a saliva-based concussion diagnostic based on Birmingham research, is to start a study on concussion in sportswomen.
Rare earth magnets, one of the building block materials for clean growth, will be recycled at a plant at Birmingham’s Tyseley Energy Park
A thin film of cellulose fibre that is invisible to the naked eye, is suitable for use on high traffic objects such as door handles and handrails.
Professor Iain Chapple will work with Sigrid to identify and develop further applications for a technology that limits oral bacteria’s access to sugars
Blood clot researchers could benefit from a new device that mimics a human vein, replacing the need for animals for some studies.
The data-driven trial will use the Dexter software platform, developed at the University to identify suitable trial participants from electronic patient records
About:Energy recently secured a £1m government-funded project from the Faraday Battery Challenge programme and has now launched its first product.
The University of Birmingham is one of eight universities in the Midlands to establish a new investment company to accelerate commercialisation activities.
Research led at Birmingham is part of a £29 million funding package from the Faraday Institution to invest in the most promising and impactful battery research
The University of Birmingham and engineering firm Stopford announce new funding for novel plastics recycling technology
The University of Birmingham is to participate in the West Midlands Innovation Accelerator announced this week by the West Midlands Combined Authority.
The University of Birmingham has facilitated more than £1million in funding for student and graduate start-ups through its incubator, UoB Elevate.
The strategic research collaboration aims to deliver products that are safe, responsible, resource-sensitive, and environmentally considerate.
The agreement with a leading manufacturer is a pivotal moment for Salinity Solutions.
Phase two trial saw significant reduction in pressure in the brain and monthly headaches
The urine-based molecular test can quickly and accurately detect bladder cancer and streamline diagnosis, reducing the need for invasive cystoscopies.
Research shows the peptide called PEPITEM could provide a revolutionary approach to reducing the risk of type 2 diabetes and other obesity-related diseases
Winner announced for Minerva Birmingham PitchUp competition, which took place at Venturefest West Midlands on March 1st.
The new phase shifter uses a liquid gallium alloy and shows low signal losses and extremely low phase deviation over a wide bandwidth.
The partnership will help reduce the time and cost of observational and clinical studies, and de-risk R&D investment decisions in healthcare and life sciences
Birmingham researchers have devised a ‘closed loop’ carbon recycling system that could radically reduce carbon dioxide emissions from the steelmaking industry
Researchers who identified a novel mechanism for platelet activation in blood clotting (thrombosis) are now turning their attention to sepsis
The validated Symptom Burden Questionnaire™ for Long COVID (SBQ™-LC) will help medical researchers develop or test new treatments.
Diagnostic device to monitor against post-surgery heart strangulation risk under development by company formed by Birmingham cardiothoracic surgeon
University of Birmingham Enterprise has won the coveted Commercial Deal of the Year award from PraxisAuril, a world-leading association for Knowledge Exchange
Tim Naughton, who co-founded engineering technology startup Salinity Solutions in 2021 has been chosen for inclusion in the TechRound ‘29under29’ listing.
Two alumni from the B-Elevate incubator selected for the Telegraph NatWest 100 Female Entrepreneurs to Watch list.
Organisers of the competition, which provides training on how to secure investment, are inviting applications from ambitious small businesses in the Midlands.
The organoids provide a micro-environment that can accept and support the survival of cells from patients with blood malignancies
The University of Birmingham spinout has secured £487k of equity investment to develop its new class of fluorescent dyes for flow cytometry.
The collaboration between University of Birmingham spin-off Marker Diagnostics, Rugby Football Union and World Rugby extended for the Women’s Rugby World Cup
Award-winning innovation from Birmingham Biotech Ltd and University of Birmingham is now available in the UK
Researchers are developing a rapid test for gum disease, which they expect to play a pivotal role in early detection of heart or lung disease, and diabetes.
Older people may be able to boost working memory with a new approach that couples online therapeutic games with a non-invasive brain stimulation technique.
Birmingham now has a new short-term incubator for MedTech companies, based at the Birmingham Research Park.
A new home for businesses looking to deliver innovation into the rail sector has been launched today by the University of Birmingham.
A new agreement will see railway expertise from academia, government and industry driving forward rail innovation at a world class rail testing centre in Wales.
Potential target could treat long-term neurological conditions like Alzheimer’s Disease and foster nerve regeneration in central nervous system injuries.
The licence is for a new testing method that is just as sensitive as PCR, but faster than a lateral flow test
The researchers identified synthetic polymers that induce biofilm formation in E. coli, a bacterium commonly used in biocatalysis.
Scientists from the University of Birmingham have shown that a brain-penetrating candidate drug can foster regeneration of damaged nerves after spinal trauma
Spinout About:Energy has closed a funding round thanks to investments from three notable technology experts.
The new polymers are designed to quicken the formation of beneficial biofilms, and are expected to result in stronger plants, and higher crop yields.
Birmingham researchers collaborated with industry to develop the device, which measures the quality of water in rivers, lakes and reservoirs.
A new beam-steering antenna increases transmission efficiency and opens frequencies for mobile communications that are inaccessible to current technologies.
Research shows how microscopic crystals grow in molten metals, and paves the way for improving the tensile strength of alloys used in casting and welding
Birmingham scientists have shown an existing drug may reduce damage after spinal cord injury, by blocking the inflammatory response in the spinal cord.
Three former students who developed software that cuts the time to mark maths and science papers have raised £800,000 to commercialise the system.
A comprehensive tool that can assess the symptoms of Long COVID has been developed at the University of Birmingham for use in research and clinical care.
An assessment and feedback platform that cuts the time taken to mark work in maths and science subjects has been designed at the University of Birmingham.
The spinout has been created to commercially deploy a platform that delivers a ‘pro-healing’ microenvironment for the leading causes of preventable blindness.
Birmingham researchers have developed a new urine test for bladder cancer that could reduce the need for invasive and time-consuming diagnostic procedures.
The brainwave biomarker is being leveraged to both identify pain sensitive individuals and change their perception of pain.
HDM-4, a strategic planning software developed at the University of Birmingham, will get a major upgrade led by the World Bank Group.
Research into sugar-based plastics shows the shape of things to come
Specialist molecular diagnostic company lands in Birmingham
New spinout brings 'omics' to chemical safety
Funding success for 'supercritical water' approach to recycling plastic packaging waste
An object hidden below ground has been located using quantum technology - a long-awaited milestone with implications for industry, human knowledge and security.
A new 'supercritical water' approach to recycling plastic packaging
Matoke Holdings has joined the community of R&D companies in the BioHub Birmingham and announced the next phase of development for its Reactive Oxygen® technology for acute, surgical and chronic wound management.
Birmingham spinout Rheality has partnered with Clean Engineering to start commercialisation for a technology that will revolutionise process control – and make manufacturing more sustainable.
New HVDC prototype and powerful economic analysis make the case for a global energy grid based on 100% renewable energy
Researchers have created a new family of polymers from sustainable sources that retain all of the same qualities as common plastics, but are also degradable and mechanically recyclable.
Applications to Minerva Birmingham's Pitch Up 2022 competition have opened. Participating businesses have the chance to pitch head-to-head to a variety of investors to win a cash prize.
New spinout from University of Birmingham and Imperial College London aims to speed up battery development
University of Birmingham Enterprise gears up for 2022
Optical cavities could be key to next generation interferometers
Vacancy IP Business Development Manager
Birmingham Biotech Ltd and the University of Birmingham have signed a licensing agreement to commercialise a novel anti-viral nasal spray that protects against COVID-19.
Research shows mass production can make customised PPE for healthcare workers
First award from beLAB1407 collaboration
The company will be field-testing an energy-efficient desalination system with eco-technology company Cornish Lithium.
Birmingham project reclaims rare earth magnets from loudspeakers
New spinout Empower Therapeutics sets its sights on reducing pain 'chronification'
Birmingham scientists discover new piece of clotting puzzle
Birmingham researchers confirm speed, simplicity and sensitivity for new COVID-19 test